StonvexLoading…
StonvexStonvexStonvexCore line items from ACA's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $571.70M | $2.88B | $2.17B | $1.37B |
Operating Income | $47.10M | $341.90M | $262.90M | $150.60M |
Net Income | $37.80M | $208.40M | $156.30M | $83.30M |
EPS (Diluted) | $0.77 | $4.24 | $3.18 | $1.70 |
Total Assets | $5.00B | $4.99B | $5.05B | $5.01B |
Total Liabilities | $2.35B | $2.34B | $2.47B | $2.50B |
Cash & Equivalents | $153.20M | $214.60M | $220.00M | $189.70M |
Free Cash Flow OCF − CapEx | $28.40M | $175.50M | $119.70M | $-1.30M |
Shares Outstanding | 49.20M | 49.00M | 49.00M | 48.90M |